BiomEdit has raised an $18.4m Series B round and is gearing up to launch its first product, a designer probiotic to tackle ...

"MAIA Biotechnology doses first patient in expansion of Phase II lung cancer trial" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

The CARES clinical programme is the largest prospective investigation in cardiac AL amyloidosis to date with a total of 406 patients enrolled from 19 countries globally, including 281 patients with ...

A fungal pathogen has rendered the Southern corroboree frog functionally extinct. Can genomics technologies pull the species ...

CRISPR construct to genetically ablate the GABA transporter GAT3 in the mouse visual cortex, with effects on population-level neuronal activity. This work is important, as it sheds light on how GAT3 ...

The Discovery and New Frontiers in Research Fund programs support world-leading innovation in the sciences and engineering.

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.

Let’s dig into the relative performance of Revvity (NYSE:RVTY) and its peers as we unravel the now-completed Q1 research tools & consumables earnings season. The life sciences subsector specializing ...

New research reveals PD-L1 expression enhances survival in advanced ovarian cancer, linking it to homologous recombination ...

Psilocybin shows promise for extending lifespan and slowing aging by preserving telomeres, new studies reveal.